ArticleParasites & vectors2019
Prevalence and risk factors for selected canine vector-borne diseases in Greece.
Article in Parasites & vectors, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.
- Filarial worms: a systematic review and meta-analysis of diversity in animals from Iran with emphasis on human cases.Parasitology · 2020Pooled it
- Efficacy of a combination of fipronil and permethrin in reducing the risk of Dirofilaria immitis transmission to dogs in field conditions.Parasites & vectors · 2026Article
- Nationwide seroprevalence of canine vector-borne pathogens in dogs in Spain.Parasites & vectors · 2026Article
- Impacts of meteorological factors on zoonotic infections in domestic cat and dog populations: A scoping review of international evidence.One health (Amsterdam, Netherlands) · 2026Review
- The Comparative Study for Detection of Canine Vector-Borne Pathogens Between Companion and Stray Dogs in Bangkok and Vicinities, Thailand.Pathogens (Basel, Switzerland) · 2026Article
- Serological Evidence of Selected Tick-Borne Pathogens andVeterinary sciences · 2026Article
- Questionnaire-Based Survey on Risk Factors and Prevalence of Major Vector-Borne Diseases in the Aegean Region of Türkiye.Veterinary sciences · 2026Article
- High seroprevalence, clinical predictors, and epidemiological risk factors ofVeterinary world · 2025Article
- Assessment of the monthly risk of dirofilariosis infection in Europe and its projection to 2100 under climate change from a One Health perspective.Parasites & vectors · 2025Article
- Infections by Ehrlichia spp., Anaplasma spp. and Babesia spp. In Puerto Ordaz, Bolívar, VenezuelaBiomedica : revista del Instituto Nacional de Salud · 2025Article
- Serological detection of Anaplasma spp., Ehrlichia spp., Borrelia burgdorferi s.l. antibodies, and Dirofilaria immitis antigen in stray dogs in Bosnia and Herzegovina.Parasitology research · 2025Article
- Comprehensive study of ticks and tick-borne diseases in dogs in Nepal: molecular identification, risk analysis and hematological alterations.BMC veterinary research · 2025Article
- Article
- Clinical Study and Serological Diagnosis of Vector-Borne Pathogens in Sardinian Dogs.Veterinary sciences · 2024Article
- Prevalence of Lyme Disease and Relapsing FeverPathogens (Basel, Switzerland) · 2024Review
- Beyond Borders:Veterinary sciences · 2024Article
- Spatial Distribution ofPathogens (Basel, Switzerland) · 2024Article
- Wildlife and parasitic infections: A One Health perspective in Greece.Current research in parasitology & vector-borne diseases · 2024Review
- Diversity and geographic distribution of haplotypes of Dirofilaria immitis across European endemic countries.Parasites & vectors · 2023Article
- Evidence of Horse Exposure toBiomolecules · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 5 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCanine vector-borne diseases (CVBDs) represent a wide group of diseases of major significance for canine health. In addition to their veterinary importance, many of these diseases are of great zoonotic concern, posing a risk of potential transmission to humans. To date, there has been scant knowledge regarding the prevalence, distribution and risk factors of CVBDs in Greece. Therefore, the objectives of the present study were to update the current knowledge on the seroprevalence of Dirofilaria immitis, Anaplasma spp., Ehrlichia spp. and Borrelia burgdorferi (sensu lato) in dogs in Greece and, furthermore, to assess possible environmental and any other risk factors associated with these infections. A total of 1000 apparently healthy and randomly selected dogs, presented in veterinary clinics, were involved at the national level (n = 66 municipalities). Serum samples were obtained from each individual dog and were tested using the SNAP
resultsOverall, 21.8% (95% CI: 19.4-24.5%) of the sampled dogs were found to be seropositive to at least one of the four pathogens examined. The most prevalent pathogen was Ehrlichia spp. (12.5%, 95% CI: 10.6-14.7) followed by D. immitis (9.0%, 95% CI: 7.8-11.5) and Anaplasma spp. (6.2%, 95% CI: 4.9-7.9). The lowest prevalence (0.1%) was recorded for B. burgdorferi (s.l.) where only one dog was found to be positive. Among the examined risk factors, low mean temperature was found to increase the prevalence of Ehrlichia spp. (P ≤ 0.001) and Anaplasma spp. (P ≤ 0.001), while low minimum temperature increased the prevalence of D. immitis (P ≤ 0.001). In addition, low total annual rainfall had an effect of the prevalence of Ehrlichia spp. (P ≤ 0.01). Altitude also had a significant effect on the prevalence of D. immitis (P ≤ 0.05) and Anaplasma spp. (P ≤ 0.01).
conclusionsTo our knowledge, this is the first large-scale seroepidemiological study of CVBDs in Greece. It has been evidenced that environmental factors such as temperature, rainfall and altitude can influence the prevalence and distribution of CVBDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.